These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5031242)

  • 1. Studies concerning the regional lymph node in cancer. II. Maintenance of immunity.
    Fisher B; Fisher ER
    Cancer; 1972 Jun; 29(6):1496-501. PubMed ID: 5031242
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies concerning the regional lymph node in cancer. V. Histologic and ultrastructural findings in regional and nonregional nodes.
    Fisher ER; Reidbord HE; Fisher B
    Lab Invest; 1973 Jan; 28(1):126-33. PubMed ID: 4569930
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies concerning the regional lymph node in cancer. IV. Tumor inhibition by regional lymph node cells.
    Fisher B; Saffer E; Fisher ER
    Cancer; 1974 Mar; 33(3):631-6. PubMed ID: 4815570
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of regional lymphadenectomy on development of concomitant immunity.
    Soloway MS; Pendergrast WJ; Myers GH
    Surg Forum; 1972; 23(0):101-2. PubMed ID: 4671039
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclophosphamide-dependent lymph node modification in lymph node metastasis of MM48 tumor cells in syngeneic mice.
    Yoshida K; Tachibana T
    Jpn J Cancer Res; 1990 Mar; 81(3):253-8. PubMed ID: 2112528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of immune depression on chemical carcinogenesis in the rat. I. Regional lymphadenectomy.
    Bolton PM
    Oncology; 1973; 27(5):430-6. PubMed ID: 4719017
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppression by cytosine arabinoside of serum-blocking factors of cell-mediated immunity to syngeneic transplants of mouse mammary tumors.
    Heppner GH; Calabresi P
    J Natl Cancer Inst; 1972 Apr; 48(4):1161-7. PubMed ID: 5023677
    [No Abstract]   [Full Text] [Related]  

  • 9. Experiences with lymphocyte immunotherapy in experimental tumor systems.
    Fisher B; Saffer EA; Fisher ER
    Cancer; 1971 Apr; 27(4):771-81. PubMed ID: 5574068
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitumor immunologic reactivity in the relatively early period after cryosurgery: experimental studies in the rat.
    Matsumura K; Sakata K; Saji S; Misao A; Kunieda T
    Cryobiology; 1982 Jun; 19(3):263-72. PubMed ID: 7105778
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of Corynebacterium parvum on cytotoxicity of regional and nonregional lymph node cells from animals with tumors present or removed.
    Fisher B; Wolmark N; Coyle J
    J Natl Cancer Inst; 1974 Dec; 53(6):1793-801. PubMed ID: 4471644
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro studies on tumor-specific immunity by using C3H mammary cancer-A cells. 3. Specificity of aggregation of sensitized lymph-node cells on target cells.
    Satoh K
    Acta Med Okayama (1952); 1967 Apr; 21(2):67-78. PubMed ID: 4229455
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on lymphatic metastasis. I. Primary immunoregulatory role of regional lymph nodes in the establishment of lymphatic metastases.
    Yoshida K; Tachibana T
    J Natl Cancer Inst; 1985 Dec; 75(6):1049-58. PubMed ID: 2866267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional lymphadenectomy and tumor immunity.
    Pendergrast WJ; Soloway MS; Myers GH; Futrell JW
    Surg Gynecol Obstet; 1976 Mar; 142(3):385-90. PubMed ID: 1251321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic competence of regional lymph nodes in patients with mammary cancer.
    Humphrey LJ; Barker C; Bokesch C; Fetter D; Amerson JR; Boehm OR
    Ann Surg; 1971 Sep; 174(3):383-91. PubMed ID: 5111281
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation between tumor-specific systemic and in situ immunity as manifested by the delayed hypersensitivity response.
    Radov LA; Haskill JS; Korn JH; Fett JW
    J Natl Cancer Inst; 1979 Jan; 62(1):103-8. PubMed ID: 281564
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies concerning the regional lymph node in cancer. VIII. Effect of two asynchronous tumor foci on lymph node cell cytotoxicity.
    Fisher B; Wolmark N; Coyle J; Saffer E; Fisher ER
    Cancer; 1975 Aug; 36(2):521-7. PubMed ID: 1157016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies concerning the regional lymph node in cancer. I. Initiation of immunity.
    Fisher B; Fisher ER
    Cancer; 1971 May; 27(5):1001-4. PubMed ID: 5581503
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 20. Action mechanism in vitro of sensitized regional lymph node cells on target cell. I. Anti-growth effect of regional lymph node cells of Ehrlich cancer transplanted mouse and that of normal lymph node cells induced by PHA, on Ehrlich cancer cell line (JTC-11).
    Konaga E
    Acta Med Okayama (1952); 1971 Aug; 25(4):269-85. PubMed ID: 4263561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.